or
forgot password
  • cancer clinical trials in texas

  • Phase I Study of Weekly Intravenous PS-341 (Bortezomib) Plus Mitoxantrone
    UT MD Anderson Cancer Center
    Houston, Texas 77030
    Prostate Cancer
    Chemotherapy Combined With Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
    M.D. Anderson Cancer Center at University of Texas
    Houston, Texas 77030
    Lung Cancer
    Oxaliplatin and Bevacizumab (Avastin™) With Either Fluorouracil and Leucovorin or Capecitabine in Treating Patients With Advanced Colorectal Cancer
    Lone Star Oncology

    Trial Locations
    Lone Star Oncology
    Medical City Dallas Hospital
    South Texas Oncology and Hematology
    Center for Cancer Prevention and Care at Scott and White Clinic
    Colorectal Cancer
    LMP-specific T-cells for Patients With Relapsed EBV-positive Lymphoma
    The Methodist Hospital
    Houston, Texas 77030
    Hodgkin Disease, Non Hodgkin Lymphoma
    Safety and Immunogenicity of Recombinant DNA and Adenovirus Expressing L523S Protein in Early Stage Non-Small Cell Lung Cancer
    Mary Crowley Medical Research Clinic

    Trial Locations
    Mary Crowley Medical Research Clinic
    Tyler Cancer Center
    Non-Small Cell Lung Cancer
    Combination Chemotherapy in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer
    Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas

    Trial Locations
    Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas
    Parkland Memorial Hospital
    Brooke Army Medical Center
    University of Texas Medical Branch
    M. D. Anderson Cancer Center at University of Texas
    Methodist Hospital
    Endometrial Cancer
    Triptorelin With Either Exemestane or Tamoxifen in Treating Premenopausal Women With Hormone-Responsive Breast Cancer
    Doctor's Hospital of Laredo
    Laredo, Texas 78041
    Estrogen Receptor-positive Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer
    Randomized Double Cord Blood Transplant Study
    UT MD Anderson Cancer Center
    Houston, Texas 77030
    Leukemia, Lymphocytic, Acute, Leukemia, Myelocytic, Acute, Leukemia, Myeloid, Chronic, Lymphoma, Non-Hodgkin
    Alopecia Areata Registry
    M.D. Anderson Cancer Center
    Houston, Texas 77030
    Alopecia Areata, Alopecia Totalis, Alopecia Universalis, Autoimmune Hair Loss, Alopecia Partialis
    Pixantrone, Cytarabine, Methylprednisolone, and Cisplatin in Treating Patients With Aggressive Non-Hodgkin's Lymphoma in First Relapse
    Baylor University Medical Center

    Trial Locations
    Baylor University Medical Center
    University of Texas - MD Anderson Cancer Center
    Lymphoma
    Imatinib Mesylate or Dasatinib in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia
    Wilford Hall Medical Center

    Trial Locations
    Wilford Hall Medical Center
    University of Texas Health Science Center at San Antonio
    Audie L Murphy Veterans Affairs Hospital
    University Hospital
    Southwest Oncology Group
    Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Chronic Phase Chronic Myelogenous Leukemia
    S0221 Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer
    UMC Southwest Cancer and Research Center

    Trial Locations
    UMC Southwest Cancer and Research Center
    University of Texas Health Science Center at San Antonio
    Veterans Affairs Medical Center - San Antonio (Murphy)
    University Hospital - San Antonio
    Breast Cancer
    Interferon Alfa-2b With or Without Bevacizumab in Treating Patients With Advanced Renal Cell Carcinoma (Kidney Cancer)
    Simmons Cancer Center at University of Texas Southwestern Medical Center - Dallas

    Trial Locations
    Simmons Cancer Center at University of Texas Southwestern Medical Center - Dallas
    CCOP - Scott and White Hospital
    Kidney Cancer
    Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
    Texas Tech University Health Sciences Center School of Medicine - Amarillo

    Trial Locations
    Texas Tech University Health Sciences Center School of Medicine - Amarillo
    Dell Children's Medical Center of Central Texas
    Driscoll Children's Hospital
    Medical City Dallas Hospital
    Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas
    Cook Children's Medical Center - Fort Worth
    University of Texas Medical Branch
    Baylor University Medical Center - Houston
    M. D. Anderson Cancer Center at University of Texas
    Covenant Children's Hospital
    University of Texas Health Science Center at San Antonio
    Methodist Children's Hospital of South Texas
    CCOP - Scott and White Hospital
    Leukemia
    Comparing Peripheral Blood Stem Cell Transplantation Versus Bone Marrow Transplantation in Individuals With Hematologic Cancers
    Baylor College of Medicine/The Methodist Hospital

    Trial Locations
    Baylor College of Medicine/The Methodist Hospital
    Texas Transplant Institute
    Leukemia, Myeloproliferative Disorders, Myelodysplastic-Myeloproliferative Diseases
    Stem Cell Transplantation in Individuals With Multiple Myeloma
    Baylor College of Medicine/The Methodist Hospital

    Trial Locations
    Baylor College of Medicine/The Methodist Hospital
    University of Texas/MD Anderson Cancer Research Center
    Texas Transplant Institute
    Multiple Myeloma
    Cytotoxic T-Lymphocytes for the Prophylaxis of Cytomegalovirus After Allogeneic Stem Cell Transplant
    Texas Children's Hospital

    Trial Locations
    Texas Children's Hospital
    The Methodist Hospital
    Cytomegalovirus Infections
    Zoledronate in Preventing Skeletal (Bone)-Related Events in Patients Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metastases
    Baylor University Medical Center - Houston
    Houston, Texas 77030-2399
    Metastatic Cancer, Prostate Cancer